Jim Simons Amneal Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$62.3 Billion
Q1 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 624,700 shares of AMRX stock, worth $4.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

624,700

Previous 686,500 9.0%

Holding current value

$4.5 Million

Previous $5.44 Million 3.73%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$7.72 - $9.01 $477,096 - $556,818	-61,800 Reduced 9.0%	624,700 $5.23 Million
Q4 2024 Feb 13, 2025	SELL	$7.69 - $9.25 $531,379 - $639,175	-69,100 Reduced 9.15%	686,500 $5.44 Million
Q3 2024 Nov 13, 2024	BUY	$6.42 - $8.83 $468,018 - $643,707	72,900 Added 10.68%	755,600 $6.29 Million
Q2 2024 Aug 09, 2024	BUY	$5.36 - $7.11 $803,839 - $1.07 Million	149,970 Added 28.15%	682,700 $4.34 Million
Q1 2024 May 13, 2024	BUY	$5.24 - $6.34 $1.7 Million - $2.06 Million	324,930 Added 156.37%	532,730 $3.23 Million
Q4 2023 Feb 13, 2024	BUY	$3.36 - $6.21 $314,832 - $581,877	93,700 Added 82.12%	207,800 $1.26 Million
Q3 2023 Nov 14, 2023	BUY	$2.76 - $4.59 $314,916 - $523,719	114,100 New	114,100 $482,000
Q4 2022 Feb 13, 2023	SELL	$1.96 - $2.61 $128,380 - $170,955	-65,500 Reduced 46.16%	76,400 $152,000
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.62 $61,610 - $110,410	-30,500 Reduced 17.69%	141,900 $287,000
Q2 2022 Aug 12, 2022	BUY	$3.01 - $4.46 $312,438 - $462,948	103,800 Added 151.31%	172,400 $548,000
Q1 2022 May 13, 2022	BUY	$3.9 - $4.89 $267,540 - $335,454	68,600 New	68,600 $286,000
Q2 2021 Aug 13, 2021	SELL	$5.12 - $6.82 $2.3 Million - $3.06 Million	-448,660 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$4.74 - $7.38 $1.31 Million - $2.04 Million	276,111 Added 160.02%	448,660 $3.02 Million
Q4 2020 Feb 10, 2021	BUY	$3.95 - $5.42 $681,568 - $935,215	172,549 New	172,549 $789,000
Q3 2019 Nov 13, 2019	SELL	$2.29 - $7.1 $164,193 - $509,070	-71,700 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$6.44 - $14.29 $2.03 Million - $4.51 Million	-315,700 Reduced 81.49%	71,700 $514,000
Q1 2019 May 14, 2019	SELL	$11.87 - $14.84 $6.72 Million - $8.4 Million	-566,300 Reduced 59.38%	387,400 $5.49 Million
Q4 2018 Feb 13, 2019	BUY	$13.09 - $21.49 $12.5 Million - $20.5 Million	953,700 New	953,700 $12.9 Million

Others Institutions Holding AMRX

# of Institutions

244

Shares Held

136M

Call Options Held

302K

Put Options Held

103K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.09B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account